Meteoadaptogenic properties of antihypoxants

V. P. Ganapolsky, P. D. Shabanov · 2009 · Eksp Klin Farmakol. 72(6):36–41

Human comparative studyBibliographic recordSource linked

This is Molekul’s research summary, not the original publication. Educational information only, not medical advice. Seek qualified healthcare help for medical conditions.

What does this source report?

The publisher abstract reports environment-dependent findings for Cytoflavin, Reamberin, Hypoxen and Mexidol.

Population and setting: Healthy men aged 20–24; Tabai chamber heat, cold and hypobaric hypoxia
Evidence type: Human comparative study
Preparation: See the original report; formulation details require verification.
Source language: See original publication
Title provenance: Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.

What are the limitations?

Noopept was not one of the tested drugs.
Comparator allocation, effect sizes and adverse-event reporting require full-text review.

Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.

Source access and review scope

Russian primary-publisher abstract and DOI checked; full text not reviewed.

Recorded source-check date: 2026-09-29. This date does not imply a completed systematic review.

Open original source or index record ↗

DOI: 10.30906/0869-2092-2009-72-6-36-41

Cite and trace this record

Original source: V. P. Ganapolsky, P. D. Shabanov. Meteoadaptogenic properties of antihypoxants Eksp Klin Farmakol. 72(6):36–41 2009.

Molekul research summary: https://molekul.io/research/antihypoxants-meteo-2009. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.

Bibliography entry

Related compound profiles

Editorial policy and evidence standards